NCT04081844View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 3, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

June 28, 2018

Conditions
Healthy
Interventions
DRUG

HCP1306

Ezetimibe 10mg / Rosuvastatin 20mg (Rosuzet)

DRUG

HGP0904

Amlodipine 5mg(Norvasc)

DRUG

HGP0608

Losartan 100mg(Cozaar)

Trial Locations (1)

Unknown

Korea University Hospital (Anam), Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04081844 - A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects. | Biotech Hunter | Biotech Hunter